Emmessar Biotech & Nutrition Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported net sales/income from operations of INR 7.921 million against INR 1.581 million a year ago. Profit from operations before other income, finance cost & exceptional items was INR 0.995 million against INR 0.049 million a year ago. Profit from ordinary activities before tax was INR 4.196 million against INR 0.171 million a year ago. Net profit for the period was INR 4.196 million or INR 0.84 per share diluted against INR 0.171 million or INR 0.03 per share diluted a year ago. For the nine months, the company reported net sales/income from operations of INR 19.081 million against INR 14.620 million a year ago. Profit from operations before other income, finance cost & exceptional items was INR 2.159 million against INR 1.175 million a year ago. Profit from ordinary activities before tax was INR 8.638 million against INR 2.304 million a year ago. Net profit for the period was INR 8.638 million or INR 1.73 per share diluted against net loss for the period of INR 6.913 million or INR 1.38 per share diluted a year ago.